Home > News > Kereos' Collaborators Present on Targeted Therapies
November 15th, 2005
Kereos' Collaborators Present on Targeted Therapies
Abstract:
Kereos, a biotechnology company developing targeted imaging agents and therapeutics to improve the detection and treatment of cancer and cardiovascular disease, announced today that the company's collaborators at Washington University School of Medicine will be presenting preclinical data on two therapeutic candidates at the American Heart Association (AHA) Scientific Sessions this week. These agents are the first cardiovascular-targeted therapeutics in Kereos' pipeline of ligand-targeted emulsions, and represent two of the first applications of nanotechnology to treating cardiovascular disease.
Source:
prnewswire
Bookmark:
| Related News Press |
Possible Futures
Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017
New metamaterial-enhanced MRI technique tested on humans May 26th, 2017
Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017
Unveiling the quantum necklace: Researchers simulate quantum necklace-like structures in superfluids May 26th, 2017
Nanomedicine
New metamaterial-enhanced MRI technique tested on humans May 26th, 2017
Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017
Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017
Sensors detect disease markers in breath May 19th, 2017
Announcements
Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017
New metamaterial-enhanced MRI technique tested on humans May 26th, 2017
Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017
Unveiling the quantum necklace: Researchers simulate quantum necklace-like structures in superfluids May 26th, 2017
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||